Supriya Kashikar

The author is the CEO of GeNext Genomics Pvt Ltd.

Biologics-based drugs at the fore – Supriya Kashikar, CEO, GeNext Genomics Pvt Ltd.

The biotech industry is witnessing unprecedented demand on many fronts. Change is taking place at the speed of light. AI and ML are revolutionising...

Stay in touch:

255,324FansLike
128,657FollowersFollow
97,058SubscribersSubscribe

Newsletter

Don't miss

Industrial Economist – End of an Epoch

Industrial Economist was founded with a vision to not...

India will be $ 55 trillion economy by 2047 – Krishnamurthy Subramanian, former CEA

Krishnamurthy Subramanian, Executive Director at the International Monetary Fund...

Swelect to invest Rs 500 crore for expansion and cell manufacturing

This will allow the company to cater on a...

A survey of startups in Tamil Nadu

“In the past five months, we’ve actively helped startups...

Super Auto Forge: Crafting Precision for 50 years…

A Golden Forge For the fiscal year, SAF registered a...